Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer
Amit Bahl, William W. Wilson, Jessica Ball, Emily Renninson et autres
gb (code pays fourni par la source)